Motexafin gadolinium-based treatment planning MRI identifies occult brain metastases amenable to stereotactic radiosurgery: Imaging results of a phase II trial of motexafin gadolinium and whole brain radiotherapy with stereotactic radiosurgery Conference

Suh, JH, Mehta, MP, Dagnault, A et al. (2006). Motexafin gadolinium-based treatment planning MRI identifies occult brain metastases amenable to stereotactic radiosurgery: Imaging results of a phase II trial of motexafin gadolinium and whole brain radiotherapy with stereotactic radiosurgery . INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 66(3), S193-S194. 10.1016/j.ijrobp.2006.07.375

Open Access International Collaboration

cited authors

  • Suh, JH; Mehta, MP; Dagnault, A; Chabot, P; Chang, EL; Fortin, MA; Grecula, JC; Nabid, A; Souhami, L; Renschler, MF

authors

date/time interval

  • November 5, 2006 -

publication date

  • January 1, 2006

webpage

published in

keywords

  • Life Sciences & Biomedicine
  • Oncology
  • Radiology, Nuclear Medicine & Medical Imaging
  • Science & Technology

Location

  • Philadelphia, PA

Digital Object Identifier (DOI)

Conference

  • 48th Annual Meeting of the American-Society-for-Therapeutic-Radiology-and-Oncology (ASTRO)

publisher

  • ELSEVIER SCIENCE INC

start page

  • S193

end page

  • S194

volume

  • 66

issue

  • 3